Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Sun Pharma launches skin cancer treatment drug in US
Sun Pharmaceutical Industries on Friday said it has launched skin cancer drug Unloxcyt in the US market. Unloxcyt (cosibelimab-ipdl) is now available in the US for healthcare professionals to prescribe for adults with metastatic cutaneous squamous…
JB Pharma net profit jumps 22% on strong domestic, global momentum
Driven by momentum at home and in international markets, the consolidated net profit of JB Chemicals & Pharmaceuticals Ltd (JB Pharma) rose by 22.2 percent year-on-year to ₹198 crore during the third quarter of the current financial year FY…
BridgeBio Pharma (NASDAQ:BBIO) Sees Large Volume Increase - Still a Buy?
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) saw unusually-high trading volume on Friday. Approximately 3,621,276 shares traded hands during mid-day trading, an increase of 15% from the previous session's volume of 3,159,396 shares.The…
OKYO Pharma (NASDAQ:OKYO) Trading Down 15.5% - What's Next?
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) shares fell 15.5% on Thursday. The stock traded as low as $2.31 and last traded at $2.39. 320,302 shares were traded during mid-day trading, an increase of 111% from the average…
Five Takeaways From The 2026 J.P. Morgan Healthcare Conference
The author Juergen Eckhardt, pictured center, speaking this week at a panel on medical innovation hosted by the WuXi Global Forum, at the JP Morgan Healthcare Conference. This week, I had the pleasure of attending the annual J.P. Morgan Conference…
DFW Capital, GPP, SK Capital eye pharma commercialization; Chicago Bears QB Caleb Williams' 888 Midas gears up for future investment plays
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of 'Moderate Buy' by Analysts
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have received an average recommendation of 'Moderate Buy' from the twenty-three research firms that are presently covering the stock, MarketBeat reports. One equities research analyst…
Stock markets end higher on rally in Infosys shares
Equity benchmark indices Sensex and Nifty ended higher on Friday, driven by a sharp jump in Infosys after the company raised its revenue growth guidance for FY26. After two days of losses, the 30-share BSE Sensex climbed 187.64 points, or 0.23 per…
Sun Pharma launches skin cancer medication in US
What's the story Sun Pharmaceutical Industries has launched its skin cancer drug, Unloxcyt (cosibelimab-ipdl), in the US. The Mumbai-based company announced that the drug is now available for prescription by healthcare professionals. It is intended…
Switzerland is asking itself: Is 10 million people too many?
DAVOS – When the population in Davos surges next week during the World Economic Forum's annual gathering, residents of the Swiss town will grit their teeth and suffer through the overcrowding, traffic chaos and disruption. After all, local…
How Crypto Is Used for Political Corruption
Subscribe here: Apple Podcasts | Spotify | YouTube | Overcast | Pocket Casts Brandon LaRoque kept his life savings in a cryptocurrency account. One morning, as he went to check his balance, he discovered that it was all missing. LaRoque is one of…
Trump's New Prescription Plan vs. Mark Cuban's: Experts Weigh In
CREDIT: Trump: Shawn Thew - Pool via CNP; Cuban: Ron Sachs/CNP / iStock.com GOBankingRates' editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services -…
A pair of transitions at the top and more leadership moves across the market
Thomson Reuters Special Services Dana Barnes has joined this subsidiary of the global financial data giant as president to lead the next phase of its strategy in the national security market. The two-decade federal market veteran most recently…
Udit Misra writes: India must widen, and deepen, its export pool to offset Trump's tariffs
India exported goods worth $38.5 billion in December 2025, a modest 1.8% increase over the $37.8-billion export figure recorded in December 2024, according to data shared by the Ministry of Commerce and Industry on Thursday. In December, India…
Bruce Broussard on leaving Humana, reputational risks of AI
This is a preview of the January 15 edition of Access Health— Tap here to get this newsletter delivered straight to your inbox on Thursday mornings. We had both rain and snow in Chicago yesterday, so I'm jealous of that 60-degree weather you…
Receive a Daily briefing on Pharma Industry News
Get Started